BSX · CUSIP 101137107
Boston Scientific Corp.
Reported by 5 of 79 curated managers in Q2 2026, in the holdings snapshot last exported 2026-10-26.
- Managers holding
- 5
- Average portfolio weight
- 0.5%
- Combined reported value
- $288.5M
- Research group
- 79
5 of the 79 superinvestors Shameless Cloning tracks reported Boston Scientific Corp. (BSX) in their Q2 2026 13F filings, worth $288.5M combined, at an average 0.5% of their portfolios. The largest positions by portfolio weight belong to Lee Ainslie (2.3%), Sarah Ketterer (0.3%), Mairs & Power Funds (0.0%).
Reporting managers
This is a historical 13F snapshot, not a live shareholder register. The count covers all matched managers; dashboard rankings use only those with at least 95% coverage. Reported value is measured at filing quarter-end, not at today's price.
| Manager / SEC filer | % of portfolio | Reported value |
|---|---|---|
| Lee AinslieMAVERICK CAPITAL LTD | 2.3% | $253.4M |
| Sarah KettererCAUSEWAY CAPITAL MANAGEMENT LLC | 0.3% | $30.7M |
| Mairs & Power FundsMAIRS & POWER INC | 0.0% | $423K |
| Dodge & Cox FundsDodge & Cox | 0.0% | $3.7M |
| Polen Capital ManagementPOLEN CAPITAL MANAGEMENT LLC | 0.0% | $203K |